ClinicalTrials.Veeva

Menu

Long-term Training Effects of Rhythmic Auditory Stimulation on Gait in Patients With Parkinson's Disease

U

University of Toronto

Status

Completed

Conditions

Intermittent Rhythmic Auditory Stimulation
Continuous Rhythmic Auditory Stimulation

Treatments

Other: Rhythmic Auditory Stimulation (RAS)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Falls are common among patients with Parkinson's Disease (PD) and are the biggest contributors to loss of independent living, long-term institutionalization, and increased mortality.

The purpose of this study was to explore whether an at-home based Rhythmic Auditory Stimulation (RAS) gait training program will decrease the number of falls in persons with PD with a history of falling. We also evaluated changes in clinical and kinematic parameters used to assess fall risk in this population.

Sixty participants diagnosed with idiopathic PD with at least 2 falls in the past 12 months, were randomly allocated into two groups. The experimental group trained daily with RAS for 24 weeks. The control group also trained daily with RAS, but discontinued training between weeks 8 and 16. During treatment patients walked for 30 minutes in a home based environment with metronome-click embedded music. Changes in clinical and kinematic parameters were assessed at baseline, weeks 8, 16, and 24.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hoehn & Yahr (HY) stage III or IV
  • At least 2 falls in the past 12 months
  • Stable antiparkinsonian medication regime
  • Ability to ambulate independently for at least 50 m.

Exclusion criteria

  • Other neurological or orthopedic conditions
  • Medically diagnosed hearing loss
  • Dementia (Mini Mental Status Exam score < 24).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Continuous RAS
Experimental group
Description:
The experimental group (continuous treatment) trained daily with RAS for 24 weeks.
Treatment:
Other: Rhythmic Auditory Stimulation (RAS)
Intermittent RAS
Active Comparator group
Description:
The control group (intermittent treatment) trained with RAS for 8 weeks, discontinued training for 8 weeks, and resumed training with RAS for 8 weeks.
Treatment:
Other: Rhythmic Auditory Stimulation (RAS)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems